Hélène Bonnet, CSR Projects, France

Hélène Bonnet, CSR Projects, France

Hélène Bonnet, CSR Projects, France

#WHD2023: how well do you know your heart?

Every year since 2000, World Heart Day has been observed; today, it has become the biggest global-awareness platform for cardiovascular health. At Sanofi, we couldn’t miss the chance to join WHD, as we chase the miracles of science to improve people’s lives with our CV medications and flu vaccines.

Global Health Unit

We believe everyone should have access to healthcare, no matter where they call home.

Bridging the Gap

We’re in Dar es Salaam, Tanzania to see how our Global Health Unit is ensuring access to healthcare through doctor visits and affordable healthcare for the most vulnerable.

Let’s Fly the Meningitis Flag

We’ve teamed up with the meningitis community to co-create a unique, global visual symbol in the fight against meningitis.

Our Paris 2024 Volunteers

We’re recruiting and training a diverse group of highly-motivated Sanofians to be volunteers at the Paris 2024 Games

Artificial Intelligence in R&D

Artificial intelligence (AI) can transform how we discover, develop, and deliver therapies. It can help us provide better care at lower cost and empower people to manage their disease.

Investing in NextGen healthcare leaders

We believe in a healthcare system where all communities feel heard, respected and understood. That is why we launched the Sanofi NextGen Scholarship – our pioneering program to bring more young people from marginalized groups into the healthcare profession. And we are delighted to announce the new academic partners who will help bring this world-first vision to life.

Sanofi Today

Hélène Bonnet, CSR Projects, France

Your Health

September 29, 2023

Know your ❤: reducing the risk of cardiovascular disease

Our latest news

October 2, 2023
Media Update: Sanofi presents new data from robust MS clinical pipeline exploring multiple approaches to address important unmet patient needs
September 29, 2023
Media Update: Sanofi completes acquisition of Qunol®
September 26, 2023
Press Release: Dupixent® (dupilumab) sBLA for treatment of eosinophilic esophagitis in children aged 1 to 11 accepted for FDA Priority Review
September 25, 2023
Press Release: Once-weekly ALTUVIIIO® approved in Japan as a new class of factor VIII therapy for hemophilia A

Explore More

Diversity, Equity, and Inclusion Report

In the first full year of our new People and Culture strategy, Diversity, Equity, and Inclusion took center stage. This report celebrates the tangible progress we’ve made towards reflecting diversity in our leadership, unleashing the full potential of our people, and achieving impact in and beyond the workplace.

Our Legacy

Our company of today is built on a heritage of turning the impossible into the possible.

Our Integrated Report 2022

Discover how we’re making the impossible possible to improve people's lives everywhere.

Explore Career Opportunities

You'll be surprised what you can achieve at Sanofi. Discover your future here.